USPTO Extends, Modifies CARES Act Deadline Relief

01 June 2020 Blog
Authors: Courtenay C. Brinckerhoff
Published To: Coronavirus Resource Center:Back to Business PharmaPatents

The United States Patent and Trademark Office (USPTO) has extended the period for deferring certain deadlines under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) with important modifications. The most general relief now only applies to small and micro entities “personally affected by the COVID-19 outbreak,” although large entities can request relief on a case-by-case basis. The USPTO also is now permitting initial applications for patent term extension under 35 USC §156 to be filed electronically.

Deferring Patent Office Deadlines under the CARES Act

As reported in this article, Section 12004 of the CARES Act granted the USPTO temporary authority to extend statutory deadlines. The USPTO’s original notice explaining how the agency would exercise that authority for patent-related deadlines was issued March 31, 2020. Those particulars were superseded by the USPTO’s April 28 notice, which revised some details and extended the deferral period to June 1, 2020. 

As set forth in the May 27, 2020 notice, the general ability to defer deadlines is extended for small and micro entities only to July 1, 2020. The notice states simply:

Specifically, for small and micro entities, filings that would have been deemed timely filed, if filed by June 1, 2020 pursuant to the CARES Act Notice dated April 28, 2020, will now be deemed timely filed if filed by July 1, 2020. 

Large entities still affected by COVID-19 can request relief on a case-by-case basis: 

For large entities, after May 31, 2020, relief will be available to those who need it on a case-by-case basis. Such requests can be submitted through a petition for an extension of time or a petition to revive. 

Additionally, for patent applicants of all sizes, the UPSTO will waive petition fees for revival of applications that became abandoned on or before June 30, 2020, due to the COVID-19 outbreak, pursuant to requirements discussed in this article.

Electronic Filing of Initial Patent Term Extension Applications 

In a separate notice, the USPTO announced that it is now (“until further notice”) permitting initial applications for patent term extension under 35 USC §156 to be filed electronically, via the USPTO’s electronic filing systems (EFS-Web or Patent Center). Consequently, the USPTO is waiving the requirements in 37 CFR §§ 1.740(b) and 1.790(b) to file two additional copies of the initial application for electronically filed applications. 

As summarized in the notice, this change gives applicants three ways to file initial patent term extension applications:

  1. via the USPTO’s electronic filing systems (EFS-Web or Patent Center);
  2. via the United States Postal Service by Priority Mail Express® under 37 CFR § 1.10 or with a certificate of mailing under 37 CFR § 1.8; or 
  3. by hand-delivery to the USPTO’s Customer Service Window.

The notice provides detailed information on electronic filing requirements, and should be consulted when filing an application for patent term extension electronically.

Answering Questions about COVID-19 Relief

The USPTO prefers that questions about these COVID-19 relief programs be emailed to The USPTO also has a CARES ACT Frequently Asked Question page

Foley has created a multi-disciplinary and multi-jurisdictional team, which has prepared a wealth of topical client resources and is prepared to help our clients meet the legal and business challenges that the coronavirus outbreak is creating for stakeholders across a range of industries. Click here for Foley’s Coronavirus Resource Center to stay apprised of relevant developments, insights and resources to support your business during this challenging time. To receive this content directly in your inbox, click here and submit the form.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.